Publication
Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohort
Journal Paper/Review - Jan 1, 2006
Simon Dagmar, Gilgen Bobalj Nicole, Schmid-Grendelmeier Peter, Braathen Lasse R, Schöni Martin H, Anliker Mark, Laffitte Emmanuel, Weber M Monika, Wiesner Alice, Wüthrich Brunello, Lübbe Jann, Schneider Dirk
Units
PubMed
Doi
Citation
Type
Journal
Publication Date
Issn Print
Pages
Brief description/objective
Controlled studies established the efficacy and good tolerability of pimecrolimus cream 1% for the treatment of atopic dermatitis but they may not reflect real-life use.